Trust Company’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,537
Closed -$89.1K 893
2025
Q3
$89.1K Hold
3,537
0.01% 185
2025
Q2
$89.1K Sell
3,537
-1
-0% -$25 0.01% 185
2025
Q1
$89K Hold
3,538
0.01% 188
2024
Q4
$88.6K Hold
3,538
0.01% 186
2024
Q3
$88.8K Buy
3,538
+507
+17% +$12.7K 0.01% 171
2024
Q2
$75.3K Hold
3,031
0.01% 165
2024
Q1
$75.2K Buy
+3,031
New +$75.1K 0.01% 166
2022
Q3
Sell
-1,999
Closed -$49K 333
2022
Q2
$49K Hold
1,999
0.01% 190
2022
Q1
$50K Buy
1,999
+483
+32% +$12.5K 0.01% 196
2021
Q4
$40K Hold
1,516
0.01% 190
2021
Q3
$41K Hold
1,516
0.01% 183
2021
Q2
$41K Sell
1,516
-301
-17% -$8.12K 0.03% 175
2021
Q1
$49K Buy
+1,817
New +$49.2K 0.04% 174

Other funds holding IBDQ

Trust Company's IBDQ Position: Q4 2025 in Review

Trust Company sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 3,537 shares — an estimated $89.1K sold.

Trust Company first reported a position in IBDQ in Q1 2021 and held it in 13 quarters. The position peaked at $89.1K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Trust Company reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Trust Company sold 3,537 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $89.1K.
  • Trust Company first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2021 and held it in 13 quarters.
  • Trust Company's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $89.1K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Trust Company's 13F filing for Q4 2025, filed 15 Jan 2026.